Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.77
-1.13 (-14.30%)
At close: Mar 31, 2025, 4:00 PM
6.30
-0.47 (-6.94%)
Pre-market: Apr 1, 2025, 4:46 AM EDT

Actuate Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Cash & Equivalents
8.642.9620.45
Cash & Short-Term Investments
8.642.9620.45
Cash Growth
192.08%-85.53%-
Prepaid Expenses
0.570.040.03
Total Current Assets
9.21320.48
Other Long-Term Assets
0.11--
Total Assets
9.32320.48
Accounts Payable
1.923.422.13
Accrued Expenses
6.883.52.21
Total Current Liabilities
8.86.924.34
Other Long-Term Liabilities
0.410.540.49
Total Liabilities
9.217.464.84
Common Stock
000
Additional Paid-In Capital
132.485.475.04
Retained Earnings
-132.38-105.09-80.35
Total Common Equity
0.1-99.63-75.31
Shareholders' Equity
0.1-4.4615.65
Total Liabilities & Equity
9.32320.48
Net Cash (Debt)
8.642.9620.45
Net Cash Growth
192.08%-85.53%-
Net Cash Per Share
1.032.0616.89
Filing Date Shares Outstanding
19.531.691.21
Total Common Shares Outstanding
19.531.691.21
Working Capital
0.41-3.9316.14
Book Value Per Share
0.01-58.93-62.21
Tangible Book Value
0.1-99.63-75.31
Tangible Book Value Per Share
0.01-58.93-62.21
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q